In January 2025, Qisda’s consolidated revenue reached NT$16.538 billion (approx. US$503.5 million), reflecting a year-over-year increase of 1.6%, but a month-over-month decrease of 12.3%.

administrator
Related Articles
Pharmacists Can Intervene in Commonly Overlooked Medication Errors
- September 12, 2025